Veru Inc (VERU)
1.48
+0.12
(+8.42%)
USD |
NASDAQ |
May 01, 16:00
1.48
0.00 (0.00%)
After-Hours: 17:43
Veru Enterprise Value: 168.94M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 168.94M |
| April 29, 2024 | 152.11M |
| April 26, 2024 | 155.03M |
| April 25, 2024 | 146.25M |
| April 24, 2024 | 162.35M |
| April 23, 2024 | 155.77M |
| April 22, 2024 | 155.03M |
| April 19, 2024 | 160.89M |
| April 18, 2024 | 176.99M |
| April 17, 2024 | 138.93M |
| April 16, 2024 | 152.84M |
| April 15, 2024 | 193.09M |
| April 12, 2024 | 191.63M |
| April 11, 2024 | 231.15M |
| April 10, 2024 | 150.64M |
| April 09, 2024 | 140.40M |
| April 08, 2024 | 119.90M |
| April 05, 2024 | 104.55M |
| April 04, 2024 | 90.63M |
| April 03, 2024 | 90.48M |
| April 02, 2024 | 82.46M |
| April 01, 2024 | 80.38M |
| March 28, 2024 | 71.61M |
| March 27, 2024 | 63.78M |
| March 26, 2024 | 58.41M |
| Date | Value |
|---|---|
| March 25, 2024 | 58.30M |
| March 22, 2024 | 51.10M |
| March 21, 2024 | 53.14M |
| March 20, 2024 | 55.49M |
| March 19, 2024 | 57.15M |
| March 18, 2024 | 52.22M |
| March 15, 2024 | 54.03M |
| March 14, 2024 | 56.97M |
| March 13, 2024 | 62.96M |
| March 12, 2024 | 61.50M |
| March 11, 2024 | 65.45M |
| March 08, 2024 | 63.91M |
| March 07, 2024 | 58.71M |
| March 06, 2024 | 63.11M |
| March 05, 2024 | 55.99M |
| March 04, 2024 | 62.08M |
| March 01, 2024 | 62.81M |
| February 29, 2024 | 57.70M |
| February 28, 2024 | 59.37M |
| February 27, 2024 | 63.72M |
| February 26, 2024 | 49.67M |
| February 23, 2024 | 55.49M |
| February 22, 2024 | 50.37M |
| February 21, 2024 | 42.03M |
| February 20, 2024 | 42.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.29M
Minimum
Jan 19 2024
1.820B
Maximum
Aug 17 2022
368.11M
Average
237.55M
Median
Jun 22 2020
Enterprise Value Benchmarks
| EyePoint Pharmaceuticals Inc | 545.97M |
| Regeneron Pharmaceuticals Inc | 88.89B |
| Bio-Path Holdings Inc | 0.869M |
| Aileron Therapeutics Inc | 58.55M |
| Scholar Rock Holding Corp | 912.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.276M |
| Revenue (Quarterly) | 2.141M |
| Total Expenses (Quarterly) | 10.94M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 53.74% |
| Profit Margin (Quarterly) | -386.6% |
| Earnings Yield | -50.68% |
| Normalized Earnings Yield | -53.69 |